28-Sept-2026 14:57:40
NATCOPHARMExpansion
NATCO PHARMA : INCREASED INVESTMENT IN EGENESIS INC. FOR $16.70 MILLION
• The investment comprises US$ 13.70 million by NATCO Pharma (Canada) Inc. and US$ 3 million by NATCO Pharma USA LLC through convertible promissory notes. • eGenesis, Inc. is a biotechnology company focused on gene editing and genome engineering for solid organ transplantation.
Natco Pharma Limited
Open attachment